Abstract
This analysis evaluated the effects of deferasirox on liver iron concentration in moderate and heavily iron-overloaded patients with β-thalassaemia from the ESCALATOR trial (n=231). Mean liver iron concentrations (LIC) decreased significantly from 21.1±8.2 to 14.2±12.1mg Fe/g dry weight (dw) at 2yr (P
Original language | English |
---|---|
Pages (from-to) | 349-354 |
Number of pages | 6 |
Journal | European Journal of Haematology |
Volume | 87 |
Issue number | 4 |
DOIs | |
Publication status | Published - Oct 2011 |
Keywords
- β-thalassaemia
- Deferasirox
- Efficacy
- Iron chelation therapy
- Iron overload
ASJC Scopus subject areas
- Hematology